General Neuromodulator Treatment Protocol

Category Name	Content
Name	Neuromodulators: Botox (OnabotulinumtoxinA), Dysport (AbobotulinumtoxinA), Daxxify (DaxxibotulinumtoxinA-lanm), Jeuveau (PrabotulinumtoxinA-xvfs), Xeomin (IncobotulinumtoxinA)
Uses	FDA-approved indications: • Botox: Glabellar lines, cervical dystonia, chronic migraines, blepharospasm, hyperhidrosis. • Dysport: Glabellar lines, cervical dystonia. • Daxxify: Glabellar lines. • Jeuveau: Glabellar lines. • Xeomin: Glabellar lines, cervical dystonia, blepharospasm. Off-label uses: Forehead lines, crow’s feet, masseter reduction, TMJ disorder, gummy smile, excessive salivation, and platysmal bands.
Route of Administration	Intramuscular (IM) or intradermal injection, depending on indication.
Frequency of Use	Maximum every 3 months (except Daxxify, which can last up to 6 months). Effects last 3–6 months depending on metabolism and treatment area.
Concentration(s)	• Botox: 100 units per vial. • Dysport: 300 units per vial. • Daxxify: 40 units per vial. • Jeuveau: 100 units per vial. • Xeomin: 100 units per vial. Standard dilution: Preservative-free saline.
Maximum Dosage	• Aesthetic use: Max 100 units per session. • Hyperhidrosis: Max 50 units per axilla (total 100 units). • Other medical uses: Based on clinical judgment.
Contraindications	• Pregnancy, breastfeeding, or planning pregnancy. • Allergy to botulinum toxin type A, human serum albumin, or gram-positive bacterial proteins. • History of severe allergic reactions, anaphylaxis, or neuromuscular disorders (e.g., Myasthenia Gravis, Lambert-Eaton Syndrome, ALS). • Active skin infections, acne, or inflammation in the treatment area. • History of bleeding disorders or use of anticoagulants. • Prior embolism, necrosis, or glabellar necrosis from previous aesthetic procedures. • Patients taking cholinesterase inhibitors (e.g., pyridostigmine, donepezil). • Patients allergic to cow’s milk protein (Dysport-specific contraindication).
Possible Side Effects	• Common: Mild bruising, swelling, tenderness, transient headache. • Rare: Eyelid or eyebrow ptosis, dry mouth, flu-like symptoms, asymmetry. • Severe: Dysphagia, respiratory distress, muscle weakness beyond treatment area (botulism-like symptoms requiring medical intervention).
Compatibility With Other Treatments/Drugs	• Safe with: Dermal fillers, most skincare treatments. • Avoid with: Recent laser resurfacing, chemical peels, or neuromodulator treatment within the last 3 months (except Daxxify, which is 6 months).
Allergies	Patients allergic to botulinum toxin A, human serum albumin, eggs, cow’s milk protein (Dysport-specific), or gram-positive bacterial proteins should not receive treatment.
Administration Time	Injection procedure takes approximately 15–30 minutes, including consultation and mapping.
Dosing/Settings	• Glabellar lines: 20–50 units • Forehead: 10–25 units • Crow’s feet: 6–12 units per side • Masseter reduction: 20–40 units per side • Hyperhidrosis: 50 units per axilla • TMJ disorder: 20–30 units per side • Gummy smile: 2–4 units per side • Platysmal bands: 10–20 units per band
What To Do If Adverse Reaction Occurs	• Ptosis: Prescribe apraclonidine (Iopidine) eye drops, instruct patient on proper application. • Anaphylaxis: Administer epinephrine (0.3 mg IM), call 911, provide airway support. • Severe dysphagia or respiratory distress: Refer to emergency care immediately. • Overcorrection: Allow time for natural resolution (3-6 months); if necessary, refer to a specialist for management.
Additional Documentation Requirements	• Signed informed consent form. • Pre-treatment photos (frontal and side views). • Medical clearance for patients with history of neuromuscular disorders, autoimmune conditions, or previous complications. • Documentation of past neuromodulator treatments, including product used and dosing history.
Post-Treatment Care Instructions	• Avoid lying down or rubbing the treated area for at least 4 hours. • No strenuous exercise, alcohol, or excessive sun exposure for 24 hours. • Monitor for signs of asymmetry or unexpected muscle weakness. • Results typically appear in 3–7 days (Daxxify may take longer), with full effect in 14 days. • Follow up in 2 weeks for touch-ups if needed.